查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423572

全球胰岛素输送设备市场预测（-2030）：按产品、分销管道、最终用户和地区分析

Insulin Delivery Devices Market Forecasts to 2030 - Global Analysis By Product (Insulin Pumps, Insulin Pens, Insulin Pen Needles, Insulin Syringes, Insulin Inhalers, Insulin Jet Injectors & Other Types), Distribution Channel, End User & By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

2023年，全球胰岛素输送设备市场规模为149亿美元，预计预测期内复合年增长率为9.4%，到2030年将达280亿美元。

胰岛素输送装置是设计用于向糖尿病患者施用胰岛素的工具或系统。它用于透过将胰岛素泵入体内来调节血糖值。这些设备有型态，包括胰岛素注射器、胰岛素笔针、胰岛素帮浦和胰岛素喷射注射器。这些设备提供了多种胰岛素给药方法，使个人能够根据自己的生活方式、偏好和胰岛素需求更有效地管理自己的病情。

根据国际糖尿病联盟（IDF）的数据，2021年约有5.37亿成年人患有糖尿病，预计到2030年这一数字将增加6.43亿。

糖尿病盛行率上升

糖尿病盛行率的不断上升正在推动胰岛素输送设备的进步。科技创新满足多元需求，提供便利精准。从传统的注射器到先进的胰岛素帮浦和笔，技术彻底改变了管理。智慧型设备整合了监测和交付，增加了患者的自主权。这些设备代表了糖尿病照护的重大进步，不仅提高了糖尿病患者的医嘱遵从性，还提高了他们的生活品质。

技术问题

胰岛素输送设备可能会出现影响胰岛素给药的技术故障。故障可能会导致胰岛素给药不正确，从而导致高血糖或低血糖。机械故障，例如针头堵塞或帮浦堵塞，需要即时更换，并可能导致胰岛素治疗的不便或中断。这些技术缺陷凸显了使用者保持警觉和定期设备检查的重要性，以确保无缝和安全的胰岛素输送。这些都是限制市场成长的因素。

采取促销倡议

胰岛素输送设备的加速倡议彻底改变了糖尿病治疗。智慧泵、连续血糖监测整合和用户友好介面等先进技术简化了管理。此外，自动胰岛素输送演算法等技术主导的功能可提供精确、即时的调整。拥抱这些创新不仅可以增强患者的能力，还可以促进医疗保健提供者和糖尿病患者之间的协作。这些都是推动市场成长的因素。

高成本

胰岛素输送设备的高价格带来了显着的缺点，主要影响了糖尿病患者的可得性和购买能力。这种经济负担往往限制了获得基本设备的机会，导致护理不足或不一致。缺乏财政资源可能会阻碍对血糖值的持续监测和有效的胰岛素管理，从而导致不良的健康结果。这些点限制了市场的成长。

COVID-19 的影响：

製造业放缓、运输问题和医疗用品需求增加导致某些设备间歇性短缺和供应延迟。此次疫情凸显了设备消毒和安全措施的重要性。製造商和使用者更加重视确保胰岛素输送装置得到适当的清洗和维护，以最大限度地降低感染风险。

预计在预测期内胰岛素笔针细分市场将是最大的

在预测期内，胰岛素笔针市场预计将是最大的。其高采用率、用户友好的设计以及不断增长的消费者吸引力是该细分市场拥有最高销售份额的一些因素。高市场份额的一个主要贡献者是製造商对创新和进步的日益关注。因此，产品创新预计将在不久的将来推动胰岛素笔针的需求。

居家照护产业预计在预测期内复合年增长率最高

由于人们对糖尿病护理的认识不断提高，预计居家照护领域在预测期内将出现最高的复合年增长率。在家使用胰岛素装置可减少等待时间、医院和诊所费用以及就诊费用。笔、注射器和泵等尖端产品结构紧凑、便于携带且始终有用。由于可用性和可及性的提高，胰岛素使用者越来越多地选择自我护理糖尿病管理解决方案。

比最大的地区

预计北美在预测期内将占据最大的市场占有率。由于糖尿病盛行率增加、胰岛素输送系统技术进步以及人口老化不断加剧等多种因素，该地区的市场正在显着成长。此外，医疗保健提供者、製造商和研究机构之间合作开发创新的胰岛素输送设备正在进一步推动该地区的市场成长。

复合年增长率最高的地区：

预计亚太地区在预测期内将维持最高的复合年增长率。由于各种因素，包括糖尿病盛行率上升、对先进胰岛素输送技术的认识不断提高以及一些国家医疗基础设施的改善，该地区的市场正在显着增长。此外，政府促进糖尿病管理和胰岛素输送系统技术进步的措施也有助于市场扩张。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球胰岛素输送设备市场：依产品

  • 胰岛素帮浦
    • 无内胎
    • 拴着的
  • 胰岛素笔针
    • 可重复使用的
    • 一次性的
  • 胰岛素笔针针
    • 安全针
    • 标准针
  • 胰岛素注射器
  • 胰岛素吸入器
  • 胰岛素喷射注射器
  • 其他类型

第六章全球胰岛素输送设备市场：依通路分类

  • 网上销售
  • 医院药房
  • 零售药房

第七章全球胰岛素输送设备市场：依最终用户分类

  • 居家照护
  • 诊所
  • 其他最终用户

第八章全球胰岛素输送设备市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 协议、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Abbott Laboratories
  • Novo Nordisk A/S
  • Wockhardt Ltd.
  • Medtronic
  • F. Hoffmann-La Roche, Ltd.
  • Becton, Dickinson and Company
  • Sanofi
  • Eli Lilly and Company
  • Biocon Ltd.
  • Roche
  • Insulet Corporation
  • B Braun Melsungen AG
  • Tandem Diabetes Care
  • Embecta Corporation
  • Ypsomed AG
Product Code: SMRC24806

According to Stratistics MRC, the Global Insulin Delivery Devices Market is accounted for $14.9 billion in 2023 and is expected to reach $28.0 billion by 2030 growing at a CAGR of 9.4% during the forecast period. Insulin delivery devices are tools or systems designed to administer insulin to individuals with diabetes. They're used to regulate blood sugar levels by delivering insulin into the body. These devices come in various forms, such as insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. They provide different methods for insulin administration, allowing individuals to manage their condition more effectively based on their lifestyle, preferences, and insulin needs.

According to International Diabetes Federation (IDF), the adult diabetes population in 2021 was approximately 537 million, and this number is expected to increase by 643 million in 2030.

Market Dynamics:

Driver:

Rising prevalence of diabetes

The rising prevalence of diabetes has fuelled advancements in insulin delivery devices. Innovations cater to diverse needs, offering convenience and precision. From traditional syringes to advanced insulin pumps and pens, technology has revolutionized management. Smart devices integrate monitoring with delivery, enhancing patient autonomy. These devices not only improve adherence but also enhance quality of life for individuals managing diabetes, marking a significant stride in diabetes care.

Restraint:

Technical issues

Insulin delivery devices can encounter technical glitches impacting insulin administration. Malfunctions pose risks of incorrect insulin delivery, leading to hyper or hypoglycemia. Mechanical failures, like needle jams or pump blockages, necessitate immediate replacement, potentially causing inconvenience or interruptions in insulin therapy. These technical drawbacks highlight the importance of user vigilance and regular device checks to ensure seamless and safe insulin delivery. These are the factors restraining the growth of the market.

Opportunity:

Adoption of facilitative initiatives

Facilitative initiatives in insulin delivery devices have revolutionized diabetic care. Advances like smart pumps, continuous glucose monitoring integration, and user-friendly interfaces streamline management. Additionally, tech-driven features, such as automated insulin delivery algorithms, offer precise, real-time adjustments. Embracing these innovations not only empowers patients but also fosters a collaborative approach between healthcare providers and individuals managing diabetes. These are the factors propelling the growth of the market.

Threat:

High cost

The high cost of insulin delivery devices poses significant disadvantages, primarily affecting accessibility and affordability for individuals managing diabetes. This financial burden often restricts access to essential equipment, leading to inadequate or inconsistent treatment. Limited affordability can result in compromised health outcomes due to the inability to consistently monitor blood sugar levels or administer insulin effectively. These are the aspects limiting the growth of the market.

Covid-19 Impact:

Manufacturing slowdowns, transportation issues, and increased demand for medical supplies led to intermittent shortages and delays in availability for certain devices. The pandemic emphasized the importance of device sanitization and safety measures. Manufacturers and users paid more attention to ensuring that insulin delivery devices were properly cleaned and maintained to minimize the risk of infection.

The insulin pens segment is expected to be the largest during the forecast period

The insulin pens segment is expected to be the largest during the forecast period. ts advantages over other products. Its high adoption rate, user-friendly design, and growing consumer appeal were some of the factors that led to this segment's highest revenue share. A significant contributing aspect to the high share is the increasing emphasis that manufacturers are placing on innovation and advances. Therefore, it is anticipated that in the near future, product innovations will drive the demand for insulin pens.

The home care segment is expected to have the highest CAGR during the forecast period

The home care segment is expected to have the highest CAGR during the forecast period due to increasing awareness of diabetes care. Insulin devices used at home reduce waiting times, hospital or clinic fees, and visitation expenses. The cutting-edge gadgets, which come in the form of pens, injectors, and pumps, are compact, extremely portable, and always useful. Because of their increased usability and increased accessibility, insulin users are choosing self-care diabetes control solutions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The market in the region has been significant, driven by various factors such as the increasing prevalence of diabetes, technological advancements in insulin delivery systems, and the growing aging population. Additionally, collaborations between healthcare providers, manufacturers, and research institutions for developing innovative insulin delivery devices have further propelled market growth in the region.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The market in the region has been witnessing significant growth due to various factors such as the rising prevalence of diabetes, increasing awareness about advanced insulin delivery technologies, and improving healthcare infrastructure in several countries. Moreover, government initiatives promoting diabetes management and technological advancements in insulin delivery systems contribute to the market's expansion.

Key players in the market

Some of the key players in Insulin Delivery Devices market include Abbott Laboratories, Novo Nordisk A/S, Wockhardt Ltd., Medtronic, F. Hoffmann-La Roche, Ltd., Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon Ltd., Roche, Insulet Corporation, B Braun Melsungen AG, Tandem Diabetes Care, Embecta Corporation and Ypsomed AG.

Key Developments:

In June 2023, Novo Nordisk entered negotiations of acquiring BIOCORP, which specialized in the design and development of medical devices. This was done for the development of FlexTouch Pen with Mallya, an add-on Bluetooth device.

In Feb 2023, Lilly and IABL, the largest healthcare provider collaborated to provide high-quality and affordable insulin in Bangladesh.

Types Covered:

  • Insulin Pumps
  • Insulin Pens
  • Insulin Pen Needles
  • Insulin Syringes
  • Insulin Inhalers
  • Insulin Jet Injectors
  • Other Types

Distribution Channels Covered:

  • Online Sales
  • Hospital Pharmacies
  • Retail Pharmacies

End Users Covered:

  • Homecare
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Insulin Delivery Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Insulin Pumps
    • 5.2.1 Tubeless
    • 5.2.2 Tethered
  • 5.3 Insulin Pens
    • 5.3.1 Reusable
    • 5.3.2 Disposable
  • 5.4 Insulin Pen Needles
    • 5.4.1 Safety
    • 5.4.2 Standard
  • 5.5 Insulin Syringes
  • 5.6 Insulin Inhalers
  • 5.7 Insulin Jet Injectors
  • 5.8 Other Types

6 Global Insulin Delivery Devices Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Online Sales
  • 6.3 Hospital Pharmacies
  • 6.4 Retail Pharmacies

7 Global Insulin Delivery Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Homecare
  • 7.3 Clinics
  • 7.4 Other End Users

8 Global Insulin Delivery Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Novo Nordisk A/S
  • 10.3 Wockhardt Ltd.
  • 10.4 Medtronic
  • 10.5 F. Hoffmann-La Roche, Ltd.
  • 10.6 Becton, Dickinson and Company
  • 10.7 Sanofi
  • 10.8 Eli Lilly and Company
  • 10.9 Biocon Ltd.
  • 10.10 Roche
  • 10.11 Insulet Corporation
  • 10.12 B Braun Melsungen AG
  • 10.13 Tandem Diabetes Care
  • 10.14 Embecta Corporation
  • 10.15 Ypsomed AG

List of Tables

  • Table 1 Global Insulin Delivery Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
  • Table 4 Global Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
  • Table 5 Global Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
  • Table 6 Global Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
  • Table 7 Global Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 8 Global Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 9 Global Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
  • Table 10 Global Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
  • Table 11 Global Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
  • Table 12 Global Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
  • Table 13 Global Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
  • Table 14 Global Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
  • Table 15 Global Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 16 Global Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 17 Global Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
  • Table 18 Global Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 19 Global Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 20 Global Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 Global Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 22 Global Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 23 Global Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 24 North America Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 25 North America Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 26 North America Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
  • Table 27 North America Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
  • Table 28 North America Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
  • Table 29 North America Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
  • Table 30 North America Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 31 North America Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 32 North America Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
  • Table 33 North America Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
  • Table 34 North America Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
  • Table 35 North America Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
  • Table 36 North America Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
  • Table 37 North America Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
  • Table 38 North America Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 39 North America Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 40 North America Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
  • Table 41 North America Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 42 North America Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 43 North America Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 44 North America Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 45 North America Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 46 North America Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 47 Europe Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 48 Europe Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 49 Europe Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
  • Table 50 Europe Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
  • Table 51 Europe Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
  • Table 52 Europe Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
  • Table 53 Europe Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 54 Europe Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 55 Europe Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
  • Table 56 Europe Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
  • Table 57 Europe Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
  • Table 58 Europe Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
  • Table 59 Europe Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
  • Table 60 Europe Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
  • Table 61 Europe Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 62 Europe Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 63 Europe Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
  • Table 64 Europe Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 65 Europe Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 66 Europe Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 67 Europe Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 68 Europe Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 69 Europe Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 70 Asia Pacific Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 71 Asia Pacific Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 72 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
  • Table 73 Asia Pacific Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
  • Table 74 Asia Pacific Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
  • Table 75 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
  • Table 76 Asia Pacific Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 77 Asia Pacific Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 78 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
  • Table 79 Asia Pacific Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
  • Table 80 Asia Pacific Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
  • Table 81 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
  • Table 82 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
  • Table 83 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
  • Table 84 Asia Pacific Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 85 Asia Pacific Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 86 Asia Pacific Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
  • Table 87 Asia Pacific Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 88 Asia Pacific Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 89 Asia Pacific Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 90 Asia Pacific Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 91 Asia Pacific Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 92 Asia Pacific Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 93 South America Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 94 South America Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 95 South America Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
  • Table 96 South America Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
  • Table 97 South America Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
  • Table 98 South America Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
  • Table 99 South America Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 100 South America Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 101 South America Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
  • Table 102 South America Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
  • Table 103 South America Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
  • Table 104 South America Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
  • Table 105 South America Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
  • Table 106 South America Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
  • Table 107 South America Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 108 South America Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 109 South America Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
  • Table 110 South America Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 111 South America Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 112 South America Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 113 South America Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 114 South America Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 115 South America Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 116 Middle East & Africa Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 117 Middle East & Africa Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 118 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
  • Table 119 Middle East & Africa Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
  • Table 120 Middle East & Africa Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
  • Table 121 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
  • Table 122 Middle East & Africa Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 123 Middle East & Africa Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 124 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
  • Table 125 Middle East & Africa Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
  • Table 126 Middle East & Africa Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
  • Table 127 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
  • Table 128 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
  • Table 129 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
  • Table 130 Middle East & Africa Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 131 Middle East & Africa Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 132 Middle East & Africa Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
  • Table 133 Middle East & Africa Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 134 Middle East & Africa Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 135 Middle East & Africa Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 136 Middle East & Africa Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 137 Middle East & Africa Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 138 Middle East & Africa Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)